Avepoint is trading 5.56% down at $12.40 in pre-market, with no clear company-specific bearish catalyst identified for August 12, 2026.

  • Recent coverage highlighted strong second-quarter results, including $124.5 million in revenue and higher full-year 2026 guidance.
  • Earlier investor commentary cited cost and foreign-exchange concerns despite the earnings beat.
  • The broader market is firmer, so macro sentiment does not clearly explain the decline.